{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"afg3l2-related-optic-atrophy-and-or-spastic-ataxia-spectrum","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"Any disorder caused by a heterozygous variant or biallelic variants in the AFG3L2 gene and characterized by a spectrum of phenotypes including optic atrophy and/or spastic ataxia.","mondoId":"MONDO:0700372","node":{"canonicalSlug":"afg3l2-related-optic-atrophy-and-or-spastic-ataxia-spectrum","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"AFG3L2-related optic atrophy and/or spastic ataxia spectrum","paragraphs":["Any disorder caused by a heterozygous variant or biallelic variants in the AFG3L2 gene and characterized by a spectrum of phenotypes including optic atrophy and/or spastic ataxia."],"scope":"exact","source":"MONDO","upstream":"https://clinicalgenome.org/affiliation/40077, PMID:32219868","url":"https://monarchinitiative.org/MONDO:0700372"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"mitochondrial DNA depletion syndrome","mondoId":"MONDO:0018158","slug":"mitochondrial-dna-depletion"},{"kind":"child","label":"spastic ataxia 5","mondoId":"MONDO:0013776","slug":"spastic-ataxia-5"},{"kind":"child","label":"optic atrophy 12","mondoId":"MONDO:0033549","slug":"optic-atrophy-12"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/28028"}],"translation":"published"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0700372\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>https://clinicalgenome.org/affiliation/40077, PMID:32219868</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Any disorder caused by a heterozygous variant or biallelic variants in the AFG3L2 gene and characterized by a spectrum of phenotypes including optic atrophy and/or spastic ataxia.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0700372\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"afg3l2-related-optic-atrophy-and-or-spastic-ataxia-spectrum","sourceDocuments":[{"name":"MONDO: AFG3L2-related optic atrophy and/or spastic ataxia spectrum","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0700372"}],"sourceNote":"","synonyms":["AFG3L2-related optic atrophy and/or spastic ataxia spectrum"],"takeawayHtml":"","title":"AFG3L2-related optic atrophy and/or spastic ataxia spectrum"},"schemaVersion":1}
